- Home
- BRTX vs SHFS Comparison
BRTX vs SHFS Comparison
Compare BRTX & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- SHFS
- Stock Information
- Founded
- BRTX 1997
- SHFS 2015
- Country
- BRTX United States
- SHFS United States
- Employees
- BRTX N/A
- SHFS N/A
- Industry
- BRTX Managed Health Care
- SHFS Finance: Consumer Services
- Sector
- BRTX Health Care
- SHFS Finance
- Exchange
- BRTX Nasdaq
- SHFS Nasdaq
- Market Cap
- BRTX 9.7M
- SHFS 9.5M
- IPO Year
- BRTX N/A
- SHFS N/A
- Fundamental
- Price
- BRTX $1.02
- SHFS $1.41
- Analyst Decision
- BRTX
- SHFS
- Analyst Count
- BRTX 0
- SHFS 0
- Target Price
- BRTX N/A
- SHFS N/A
- AVG Volume (30 Days)
- BRTX 98.9K
- SHFS 265.8K
- Earning Date
- BRTX 11-12-2025
- SHFS 11-12-2025
- Dividend Yield
- BRTX N/A
- SHFS N/A
- EPS Growth
- BRTX N/A
- SHFS N/A
- EPS
- BRTX N/A
- SHFS N/A
- Revenue
- BRTX $383,400.00
- SHFS $9,988,158.00
- Revenue This Year
- BRTX $232.67
- SHFS N/A
- Revenue Next Year
- BRTX $52.92
- SHFS N/A
- P/E Ratio
- BRTX N/A
- SHFS N/A
- Revenue Growth
- BRTX 1.70
- SHFS N/A
- 52 Week Low
- BRTX $1.00
- SHFS $1.29
- 52 Week High
- BRTX $2.55
- SHFS $10.53
- Technical
- Relative Strength Index (RSI)
- BRTX 32.26
- SHFS 28.42
- Support Level
- BRTX $1.00
- SHFS $1.36
- Resistance Level
- BRTX $1.45
- SHFS $1.55
- Average True Range (ATR)
- BRTX 0.12
- SHFS 0.22
- MACD
- BRTX -0.03
- SHFS 0.03
- Stochastic Oscillator
- BRTX 17.40
- SHFS 6.83
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.